Cargando…
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
BACKGROUND: Chemotherapy and/or immunotherapy are first-line treatments for advanced muscle-invasive bladder cancer (BCa), but the unsatisfactory objective response rate to these treatments yields poor 5-year patient survival. Discovery of therapeutic targets essential for BCa maintenance is critica...
Autores principales: | Zhang, Jingtong, Zhou, Qianghua, Xie, Keji, Cheng, Liang, Peng, Shengmeng, Xie, Ruihui, Liu, Lixuan, Zhang, Yangjie, Dong, Wen, Han, Jinli, Huang, Ming, Chen, Yuelong, Lin, Tianxin, Huang, Jian, Chen, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215817/ https://www.ncbi.nlm.nih.gov/pubmed/34154613 http://dx.doi.org/10.1186/s13046-021-01989-5 |
Ejemplares similares
-
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer
por: Zhou, Qianghua, et al.
Publicado: (2021) -
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program
por: Huang, Ming, et al.
Publicado: (2022) -
TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination
por: Zhou, Qianghua, et al.
Publicado: (2023) -
Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer
por: Chen, Xu, et al.
Publicado: (2016) -
Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis
por: Dong, Wei, et al.
Publicado: (2019)